Suzhou Zelgen Biopharmaceuticals Co.Ltd(688266)

junho 1, 2022

Suzhou Zelgen Biopharmaceuticals Co.Ltd(688266) . O cloridrato de jactinib é um novo tipo de medicamento inibidor de JAK desenvolvido independentemente pela empresa, que pertence à droga nova classe 1. A empresa possui os direitos de propriedade intelectual independentes do produto.

- Advertisment -

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Sempre ativado

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duração	Descrição
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Suzhou Zelgen Biopharmaceuticals Co.Ltd(688266)

Tolerância zero! Ações regulatórias pesadas! Estas duas empresas podem ser retiradas da li...

Relâmpago! Falta o proprietário benéfico da empresa! Possivelmente envolvido em um caso im...

O presidente do conselho de administração da “Vara dos Dentes” foi arquivado p...

Kalite: Anúncio de oferta pública inicial de ações e listagem no GEM

Matriz: Opinião jurídica do escritório Guoco (Shenzhen) sobre a oferta pública inicial de ...

Tecnologia Weigang: Prospecto Inicial de Oferta Pública

Weigang Technology: Anúncio da Oferta Pública Inicial de Ações

Weigang Technology: Resumo do Prospecto Inicial de Oferta Pública

Weigang Technology: Anúncio especial sobre os riscos de investimento da oferta pública ini...

601136:Primeira Oferta Pública de Ações por Títulos de Capital Primeiro Anúncio Especial s...

601136:Anúncio do Resultado Preliminar da Cotação e Adiamento da Oferta Pública Inicial de...